Clinical trials: Adult Patients Who Are Receiving Oncologic Care
Adult Patients Who Are Receiving Oncologic Care
Informing Pain Treatment Using Pharmacogenomic Analysis
This is a randomized, prospective study to evaluate the effects of preemptive pharmacogenomic (PGx) testing on opioid dosing decisions/selections and pain score in cancer patients.
- Trial name
- C-PAIN (NCT06511401)
- Testing
- Pharmacogenomic (PGx) results.
- Where
- United States
- Volunteers
- 800 people
- Sponsor
- University of Chicago